Adenosine modifications impede SARS-CoV-2 RNA-dependent RNA transcription
- Laura R. Snyder1,
- Ingrid Kilde2,
- Artem Nemudryi3,
- Blake Wiedenheft3,
- Markos Koutmos1,2,4 and
- Kristin S. Koutmou1,2
- 1Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, USA
- 2Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan 48109, USA
- 3Department of Microbiology and Cell Biology, Montana State University, Bozeman, Montana 59717, USA
- 4Department of Biophysics, University of Michigan, Ann Arbor, Michigan 48109, USA
- Corresponding author: kkoutmou{at}umich.edu
-
Handling editor: Eric Phizicky
Abstract
SARS-CoV-2, the causative virus of the COVID-19 pandemic, follows SARS and MERS as recent zoonotic coronaviruses causing severe respiratory illness and death in humans. The recurrent impact of zoonotic coronaviruses demands a better understanding of their fundamental molecular biochemistry. Nucleoside modifications, which modulate many steps of the RNA life cycle, have been found in SARS-CoV-2 RNA, although whether they confer a pro- or antiviral effect is unknown. Regardless, the viral RNA-dependent RNA polymerase will encounter these modifications as it transcribes through the viral genomic RNA. We investigated the functional consequences of nucleoside modification on the pre-steady state kinetics of SARS-CoV-2 RNA-dependent RNA transcription using an in vitro reconstituted transcription system with modified RNA templates. Our findings show that N6-methyladenosine and 2′-O-methyladenosine modifications slow the rate of viral transcription at magnitudes specific to each modification, which has the potential to impact SARS-CoV-2 genome maintenance.
Keywords
Footnotes
-
Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.079991.124.
-
Freely available online through the RNA Open Access option.
- Received February 16, 2024.
- Accepted May 20, 2024.
This article, published in RNA, is available under a Creative Commons License (Attribution 4.0 International), as described at http://creativecommons.org/licenses/by/4.0/.










